Cannabis is a rapidly growing industry; in 2019, overall sales of cannabis products legal under state law were estimated to be worth $13.6 billion, with an expected increase to $29.7 billion by 2025. While marijuana remains a...more
12/3/2020
/ Cannabidiol (CBD) oil ,
Cannabis Products ,
Controlled Substances ,
Cosmetics ,
Dietary Supplements ,
Food and Drug Administration (FDA) ,
Intellectual Property Protection ,
Marijuana ,
Marijuana Related Businesses ,
Patent Litigation ,
Patents ,
Popular ,
Trademark Registration ,
Trademarks ,
USPTO
A patent does not ordinarily change claim scope right before trial. The patent claims at the start of case are the claims that must be proven invalid or shown not to be infringed. However, if a defendant places the patent...more
Inventors should not delay the filing of their patent applications, and preferably should file within one year of any commercialization of the invention, as confirmed by the Supreme Court on January 22, 2019....more
1/31/2019
/ America Invents Act ,
Appeals ,
Assignment of Inventions ,
Confidentiality Agreements ,
Helsinn Healthcare SA v Teva Pharmaceuticals USA Inc ,
Inventions ,
On-Sale Bar ,
Patent Applications ,
Patent Infringement ,
Patents ,
Pharmaceutical Industry ,
Pharmaceutical Patents ,
Public Use ,
Reaffirmation ,
Reversal ,
SCOTUS ,
Section 102 ,
Third-Party Relationships
Effective June 1, 2018, the District of Massachusetts has adopted a new Local Patent Rule 16.6. The new rule is the result of a multi-year process and is a comprehensive revision of the rule. It will apply to all patent cases...more